UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enseigner, former, intervenir dans le champ de la petite enfance

Pueyo, Bernard

2009

Volltextzugriff (PDF)

Formation aux métiers de la petite enfance et analyse des pratiques

Éducation et socialisation, 2012-12, Vol.32

2012

Volltextzugriff (PDF)

Naissance d’une nouvelle collection : « Psychosociologie(s)

Nouvelle revue de psychosociologie, 2022-11, Vol.N° 34 (2), p.235-238

2022

Volltextzugriff (PDF)

Former à l'intervention socio-éducative: Perspectives psychosociologiques

Connexions (Paris), 2010-06, Vol.n° 93 (1), p.147-165

Pueyo, Bernard

2010

Volltextzugriff (PDF)

Former à l'intervention socio-éducative

Connexions (Paris), 2010, Vol.93 (1), p.147-165

Pueyo, Bernard

2010

Volltextzugriff (PDF)

Magnetic fabrics in the Western Central-Pyrenees: An overview

Tectonophysics, 2014-08, Vol.629, p.303-318

2014

Volltextzugriff (PDF)

THE AGGRECAN ARGS NEOEPITOPE IN A PHASE 2 CLINICAL TRIAL TARGETING OSTEOARTHRITIS

Osteoarthritis and cartilage, 2024-04, Vol.32, p.S111-S112

2024

Volltextzugriff (PDF)

149 - THE AGGRECAN ARGS NEOEPITOPE IN A PHASE 2 CLINICAL TRIAL TARGETING OSTEOARTHRITIS

Osteoarthritis and cartilage, 2024-04, Vol.32, p.S111-S112

2024

Volltextzugriff (PDF)

Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial

Osteoarthritis and cartilage, 2023-07, Vol.31 (7), p.985-994

2023

Volltextzugriff (PDF)

Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis

Osteoarthritis and cartilage, 2024-06, p.1

2024

Volltextzugriff (PDF)

FRI0411 SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY MALE JAPANESE SUBJECTS OF THE ADAMTS-5 INHIBITOR S201086/GLPG1972, A POTENTIAL NEW TREATMENT IN OA

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.804-805

2020

Volltextzugriff (PDF)

Study design of a phase 2 clinical trial with a disease-modifying Osteoarthritis drug candidate GLPG1972/S201086: The roccella trial

Osteoarthritis and cartilage, 2020-04, Vol.28, p.S499-S500

2020

Volltextzugriff (PDF)

A simple combination criteria increase the likelihood to observe cartilage loss in patients with osteoarthritis

Osteoarthritis and cartilage, 2020-04, Vol.28, p.S387-S388

2020

Volltextzugriff (PDF)

FRI0393 BASELINE CHARACTERISTICS OF THE STUDY POPULATION IN ROCCELLA, A PHASE 2 CLINICAL TRIAL EVALUATING THE EFFICACY AND THE SAFETY OF S201086/GLPG1972 IN PATIENTS WITH KNEE OSTEOARTHRITIS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.794-795

2020

Volltextzugriff (PDF)

AB0860 STUDY DESIGN OF ROCCELLA: A PHASE 2 CLINICAL TRIAL WITH A DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE GLPG1972/S201086

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1737-1737

2020

Volltextzugriff (PDF)

ExoEarth yield landscape for future direct imaging space telescopes

Journal of astronomical telescopes, instruments, and systems, 2019-05, Vol.5 (2), p.1

Stark, Christopher C.

2019

Volltextzugriff (PDF)

The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis

Osteoarthritis and cartilage open, 2021-12, Vol.3 (4), p.100209-100209, Article 100209

2021

Volltextzugriff (PDF)

A simple inclusion criteria combination increases the rate of cartilage loss in patients with knee osteoarthritis

Osteoarthritis and cartilage open, 2021-09, Vol.3 (3), p.100188-100188, Article 100188

2021

Volltextzugriff (PDF)

Efficacy and safety of s201086/GLPG1972, an ADAMTS-5 inhibitor, in patients with knee osteoarthritis: roccella, a 52-week, randomized, double-blind, dose-ranging phase 2 study

Osteoarthritis and cartilage, 2021-04, Vol.29, p.S264

2021

Volltextzugriff (PDF)

Crisis sanitaria y crisis del trabajo: ¿una oportunidad en el caos?

Sociología del Trabajo, 2020-07, p.17-21

2020

Volltextzugriff (PDF)

Multi-episodic remagnetization related to deformation in the Pyrenean Internal Sierras

Geophysical journal international, 2015-05, Vol.201 (2), p.891-914

2015

Volltextzugriff (PDF)

PHASE II CLINICAL TRIAL WITH AN AMPA-POSITIVE ALLOSTERIC MODULATOR (S 47445): BASELINE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS SUFFERING FROM ALZHEIMER’S DISEASE AT MILD TO MODERATE STAGES WITH DEPRESSIVE SYMPTOMS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P575-P575

2017

Volltextzugriff (PDF)

A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms

Alzheimer's & dementia : translational research & clinical interventions, 2019, Vol.5 (1), p.231-240

2019

Volltextzugriff (PDF)

Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-α

Blood, 1998-12, Vol.92 (11), p.4059-4065

1998

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(29)
Bücher
(1)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Enseigner, former, intervenir dans le champ de la petite enfance

Formation aux métiers de la petite enfance et analyse des pratiques

Naissance d’une nouvelle collection : « Psychosociologie(s)

Former à l'intervention socio-éducative: Perspectives psychosociologiques

Former à l'intervention socio-éducative

Magnetic fabrics in the Western Central-Pyrenees: An overview

THE AGGRECAN ARGS NEOEPITOPE IN A PHASE 2 CLINICAL TRIAL TARGETING OSTEOARTHRITIS

149 - THE AGGRECAN ARGS NEOEPITOPE IN A PHASE 2 CLINICAL TRIAL TARGETING OSTEOARTHRITIS

Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial

Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis

FRI0411 SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY MALE JAPANESE SUBJECTS OF THE ADAMTS-5 INHIBITOR S201086/GLPG1972, A POTENTIAL NEW TREATMENT IN OA

Study design of a phase 2 clinical trial with a disease-modifying Osteoarthritis drug candidate GLPG1972/S201086: The roccella trial

A simple combination criteria increase the likelihood to observe cartilage loss in patients with osteoarthritis

FRI0393 BASELINE CHARACTERISTICS OF THE STUDY POPULATION IN ROCCELLA, A PHASE 2 CLINICAL TRIAL EVALUATING THE EFFICACY AND THE SAFETY OF S201086/GLPG1972 IN PATIENTS WITH KNEE OSTEOARTHRITIS

AB0860 STUDY DESIGN OF ROCCELLA: A PHASE 2 CLINICAL TRIAL WITH A DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE GLPG1972/S201086

ExoEarth yield landscape for future direct imaging space telescopes

The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis

A simple inclusion criteria combination increases the rate of cartilage loss in patients with knee osteoarthritis

Efficacy and safety of s201086/GLPG1972, an ADAMTS-5 inhibitor, in patients with knee osteoarthritis: roccella, a 52-week, randomized, double-blind, dose-ranging phase 2 study

Crisis sanitaria y crisis del trabajo: ¿una oportunidad en el caos?

Multi-episodic remagnetization related to deformation in the Pyrenean Internal Sierras

PHASE II CLINICAL TRIAL WITH AN AMPA-POSITIVE ALLOSTERIC MODULATOR (S 47445): BASELINE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS SUFFERING FROM ALZHEIMER’S DISEASE AT MILD TO MODERATE STAGES WITH DEPRESSIVE SYMPTOMS

A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms

Le programme de recherche cours d’action (2)

Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-α

Suchergebnisse filtern